Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based natural products company ChromaDex has licensed exclusive worldwide rights from the University of Mississippi for several patents with US Patent numbers 7,205,284 and 7,846,452 related to the isolation and use of immunostimulatory extracts from microalgae.
Subscribe to our email newsletter
The company intends to create a branded ingredient technology that will be introduced in early 2015 and will target the immune support and sport nutrition markets.
After the launch, this will be the fifth branded patented ingredient technology and will join the company’s NIAGEN, PURENERGY, pTeroPure and ProC3G.
ChromaDex founder and CEO Frank Jaksch said: "There is a very large existing market for immune support products and the acquisition of this patented technology will enable us to provide a new, science-backed ingredient option for our customers."
The company said that the licensed technology covers patented and proprietary preparations from food-grade microalgae that are rich in compounds that activate innate immune cells.
University of Mississippi director of technology management Walt Chambliss said: "ChromaDex is a valued partner of the University of Mississippi and has successfully commercialized other technologies from our School of Pharmacy and the National Center for Natural Products Research."
ChromaDex offers science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries.